Olympus 2014 Annual Report Download - page 52

Thousands of U.S. dollars
For the year ended March 31, 2014
Medical
LifeScience
andIndustrial Imaging
Informationand
Communication Others Total Adjustments
Consolidated
Total
Net sales:
Third parties ......................................... $4,779,573 $956,408 $933,117 $— $256,009 $6,925,107 $ — $6,925,107
Intersegment ........................................ 1,058 349 126 — 2,894 4,427 (4,427) —
Total ............................................................ $4,780,631 $956,757 $933,243 $— $258,903 $6,929,534 $ (4,427) $6,925,107
Segment profi t (loss) .................................... $1,094,515 $ 47,913 $ (89,146) $— $ (52,000) $1,001,282 $ (288,224) $ 713,058
Assets ......................................................... 5,427,699 918,136 764,369 — 229,155 7,339,359 2,636,126 9,975,485
Depreciation and amortization ..................... 244,845 47,019 16,806 — 8,796 317,466 40,301 357,767
Amortization of goodwill ............................... 81,825 8,942 — — 1,049 91,816 — 91,816
Capital expenditures .................................... 259,408 43,670 33,942 — 7,931 344,951 22,136 367,087
Notes:
1. Segment profi t (loss) is adjusted to agree with operating income on the consolidated statements of operations.
2. Adjustments for segment profi t and loss include ¥(29,280) million and ¥(29,687) million ($(288,224) thousand) for the years ended March 31, 2013 and 2014, respectively, of corporate
general administration and research and development center expenses, which are not allocable to the reportable segments.
3. Adjustments for segment assets include ¥220,681 million and ¥271,521 million ($2,636,126 thousand) as of March 31, 2013 and 2014, respectively, of corporate assets, which are not
allocable to the reportable segments.
4. Adjustments for depreciation and amortization include ¥4,508 million and ¥4,151 million ($40,301 thousand) for the years ended March 31, 2013 and 2014, respectively, of depreciation
and amortization for corporate assets, which are not allocable to the reportable segments.
5. Adjustments for capital expenditures include ¥2,400 million and ¥2,280 million ($22,136 thousand) for the years ended March 31, 2013 and 2014, respectively, of the increase in corpo-
rate assets, which are not allocable to the reportable segments.
(4) Related information
(a) Sales by destination
Net sales to third parties by countries or areas grouped according to geographical classifi cation for the years ended March 31, 2013 and
2014 are summarized as follows:
Millions of yen
Thousands of
U.S. dollars
2013 2014 2014
to Japan ............................................................................................................................................... ¥287,025 ¥172,583 $1,675,564
to North America .................................................................................................................................. 177,233 216,098 2,098,039
to Europe ............................................................................................................................................. 157,179 184,012 1,786,524
to Asia .................................................................................................................................................. 102,395 118,717 1,152,592
to Other areas ...................................................................................................................................... 20,019 21,876 212,388
¥743,851 ¥713,286 $6,925,107
Note:
Each destination is determined by geographical adjacency.
North America includes the United States and Canada.
Europe includes Germany, the United Kingdom, France and other countries.
Asia includes Singapore, Hong Kong, China, South Korea, Australia and other countries.
Other areas include Central and South America, Africa and others.
(b) Property, plant and equipment by geographic location
Property, plant and equipment by geographical countries or areas as of March 31, 2013 and 2014 are summarized as follows:
Millions of yen
Thousands of
U.S. dollars
2013 2014 2014
Japan ................................................................................................................................................... ¥ 53,952 ¥ 53,748 $ 521,825
America ................................................................................................................................................ 35,948 35,550 345,146
Europe ................................................................................................................................................. 25,842 30,037 291,621
Asia ...................................................................................................................................................... 14,060 16,105 156,359
¥129,802 ¥135,440 $1,314,951
Note:
Each geographic location is determined by geographical adjacency.
America includes the United States, Canada, Mexico and Brazil.
Europe includes Germany, the United Kingdom, France and other countries.
Asia includes Singapore, Hong Kong, China, South Korea, Australia and other countries.
The “Medical Business” manufactures and sells medical endoscopes, surgical endoscopes, endotherapy devices and other products.
The “Life Science and Industrial Business” manufactures and sells biological microscopes, industrial microscopes, industrial endoscopes,
non-destructive testing equipment and other products. The “Imaging Business” manufactures and sells digital cameras, voice recorders
andother products. The “Others” business manufactures and sells biomedical materials and conducts system development and other
business activities.
The Company transferred its Information & Communication Business of ITX Corporation, Former ITX, which was previously classifi ed in
the Group’s Information and Communication segment on September 28, 2012, to newly established ITX Corporation, New ITX, which was
then sold and then transferred New ITX to IJ Holdings Inc., a wholly owned subsidiary of a partnership operated and managed by Japan
Industrial Partners, Inc. As a result, this newly established company was excluded from the scope of consolidation at the same date.
(2) Method of calculating amounts of net sales, profi t/loss, assets, and other items
The accounting policies of the segments are basically the same as those described in the signifi cant accounting policies in Note 1 “Summary
of signifi cant accounting policies.” Segment profi t or loss corresponds to operating income on the consolidated statement of operations.
The internal sales or transfer among segments are based on actual market prices.
(3) Information concerning net sales and profi t (loss), assets and other items by reportable segment
Millions of yen
For the year ended March 31, 2013
Medical
Life Science
and Industrial Imaging
Information and
Communication Others Total Adjustments
Consolidated
Total
Net sales:
Third parties ......................................... ¥394,724 ¥85,513 ¥107,638 ¥114,243 ¥41,733 ¥743,851 ¥ — ¥743,851
Intersegment ........................................ 159 10 37 — 252 458 (458) —
Total ............................................................ ¥394,883 ¥85,523 ¥107,675 ¥114,243 ¥41,985 ¥744,309 ¥ (458) ¥743,851
Segment profi t (loss) .................................... ¥ 87,069 ¥ 3,527 ¥ (23,073) ¥ 1,704 ¥ (4,870) ¥ 64,357 ¥ (29,280) ¥ 35,077
Assets ......................................................... 505,302 89,995 81,740 — 62,364 739,401 220,681 960,082
Depreciation and amortization ..................... 20,270 4,420 2,591 283 1,827 29,391 4,508 33,899
Amortization of goodwill ............................... 7,032 770 — 1,504 377 9,683 — 9,683
Capital expenditures .................................... 17,147 3,429 3,076 231 1,826 25,709 2,400 28,109
Millions of yen
For the year ended March 31, 2014
Medical
LifeScience
andIndustrial Imaging
Informationand
Communication Others Total Adjustments
Consolidated
Total
Net sales:
Third parties ......................................... ¥492,296 ¥98,510 ¥96,111 ¥— ¥26,369 ¥713,286 ¥ — ¥ 713,286
Intersegment ........................................ 109 10 13 — 298 456 (456) —
Total ............................................................ ¥492,405 ¥98,546 ¥96,124 ¥— ¥26,667 ¥713,742 ¥ (456) ¥ 713,286
Segment profi t (loss) .................................... ¥112,735 ¥ 4,935 ¥ (9,182) ¥— ¥ (5,356) ¥103,132 ¥ (29,687) ¥ 73,445
Assets ......................................................... 559,053 94,568 78,730 — 23,603 755,954 271,521 1,027,475
Depreciation and amortization ..................... 25,219 4,843 1,731 — 906 32,699 4,151 36,850
Amortization of goodwill ............................... 8,428 921 — — 108 9,457 — 9,457
Capital expenditures .................................... 26,719 4,498 3,496 — 817 35,530 2,280 37,810
Notes to the Consolidated Financial Statements
101
OLYMPUS Annual Report 2014
100 OLYMPUS Annual Report 2014